William Blair Maintains Verve Therapeutics(VERV.US) With Buy Rating

Moomoo NewsFeb 21 10:31 ET · Ratings

CCORF Maintains Verve Therapeutics(VERV.US) With Buy Rating, Maintains Target Price $32

Moomoo NewsFeb 21 07:33 ET · Ratings

Optimistic Outlook for Verve Therapeutics Amid Promising Developments and Strategic Partnerships

TipRanksFeb 21 07:16 ET

$VERV Stock Is up 9% Today. Here's What We See in Our Data.

Quiver QuantitativeFeb 14 10:31 ET

BMO Capital Maintains Verve Therapeutics(VERV.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsFeb 7 07:33 ET · Ratings

Buy Rating for Verve Therapeutics: VERVE-102's Enhanced Safety and Promising Efficacy Boost Investor Confidence

TipRanksFeb 7 07:26 ET · Ratings